Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

Mari M. Kitahata; Stephen J. Gange; Alison G. Abraham; Barry Merriman; Michael S. Saag; Amy C. Justice; Robert S. Hogg; Steven G. Deeks; Joseph J. Eron; John T. Brooks; Sean B. Rourke; M. John Gill; Ronald J. Bosch; Jeffrey N. Martin; Marina B. Klein; Lisa P. Jacobson; Benigno Rodriguez; Timothy R. Sterling; Gregory D. Kirk; Sonia Napravnik; Anita R. Rachlis; Liviana M. Calzavara; Michael A. Horberg; Michael J. Silverberg; Kelly A. Gebo; James J. Goedert; Constance A. Benson; Ann C. Collier; Stephen E. Van Rompaey; Heidi M. Crane; Rosemary G. McKaig; Bryan Lau; Aimee M. Freeman; Richard D. Moore

Journal ArticleOPEN ACCESS

Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

Kitahata M
Gange S
Abraham A
et al.

New England Journal of Medicine (2009) 360(18) 1815-1826

DOI: 10.1056/nejmoa0807252

983Citations

506Readers

Abstract

The optimal time for the initiation of antiretroviral therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection is uncertain.

Cite

CITATION STYLE

APA

Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., … Moore, R. D. (2009). Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival. New England Journal of Medicine, 360(18), 1815–1826. https://doi.org/10.1056/nejmoa0807252

Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

Abstract

Cite

Register to see more suggestions